Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer

Johnson, 1975, Synthesis of chlorozotocin, the 2 chloroethyl analog of the anti-cancer antibiotic streptozotocin, J. med. Chem., 18, 104, 10.1021/jm00235a023 Schein, 1976, Pharmacology of chlorozotocin (NSC-178248), a new nitrosourea antitumor agent, Cancer Treat. Rep., 60, 801 Anderson, 1975, Chlorozotocin 2-[3(2-chlorozotocin)-3-nitrosoureido]-d-glucopyranose, an antitumor agent with modified bone marrow toxicity, Cancer Res., 35, 761 Hoth, 1978, Phase I studies of chlorozotocin, Clin. Pharmacol. Ther., 23, 712, 10.1002/cpt1978236712 Gralla, 1979, Phase I trial of chlorozotocin, Cancer Treat. Rep., 63, 17 Gralla, 1979, Phase II evaluation of chlorozotocin in patients with renal cell carcinoma, Cancer Treat. Rep., 63, 1007 Gralla, 1979, Toxicology studies in mice, beagle dogs and rhesus monkeys given chlorozotocin (NSC-178248), Toxicology, 12, 31, 10.1016/0300-483X(79)90029-5